SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

NGL Fine-Chem - Quaterly Results

10 Nov 2023 Evaluate
The revenue for the September 2023 quarter is pegged at Rs. 794.38 millions, about 22.30% up against Rs. 649.53 millions recorded during the year-ago period.The Total revenue for the quarter ended September 2023 of  Rs. 109.69  millions  grew by 120.97% from Rs. 49.64 millions.OP of the company witnessed a marginal growth to 168.94 millions from 88.50 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 794.38 649.53 22.30 1485.51 1285.30 15.58 2750.52 3186.67 -13.69
Other Income 37.64 41.00 -8.20 75.66 71.07 6.46 76.12 126.40 -39.78
PBIDT 168.94 88.50 90.89 282.97 119.73 136.34 356.96 782.09 -54.36
Interest 3.62 1.20 201.67 6.05 6.18 -2.10 11.97 15.62 -23.37
PBDT 165.32 87.30 89.37 276.92 113.55 143.87 344.99 766.47 -54.99
Depreciation 20.17 20.19 -0.10 40.16 39.77 0.98 78.99 76.73 2.95
PBT 145.15 67.11 116.29 236.76 73.78 220.90 266.00 689.74 -61.43
TAX 35.46 17.47 102.98 49.01 19.02 157.68 64.81 167.28 -61.26
Deferred Tax 1.06 1.62 -34.57 2.78 -5.58 -149.82 -7.29 -4.22 72.75
PAT 109.69 49.64 120.97 187.75 54.76 242.86 201.19 522.46 -61.49
Equity 30.89 30.89 0.00 30.89 30.89 0.00 30.89 30.89 0.00
PBIDTM(%) 21.27 13.63 56.09 19.05 9.32 104.49 12.98 24.54 -47.12

NGL Fine-Chem Share Price

2229.75 -25.30 (-1.12%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×